XIX International AIDS Conference. Interview with Adeeba Kamarulzaman from the University of Malaya in Kuala Lumpur, Malaysia. She talks about the obstacles and possibilities of ending HIV and AIDS.

XIX International AIDS Conference. Session on Pediatrics with medical doctors and scientists discussing prevention of mother-to-child transmission and the development of antiretroviral treatments suitable for infants and small children.

XIX International AIDS Conference. Session "Gender and Science: Shifting the Paradigm in HIV Research" discussing the inclusion of structural and biological gender factors as part of HIV research, and the participation of women living with HIV in clinical trials.

XIX International AIDS Conference. Interview with Bernhard Schwartzlander from UNAIDS in Geneva. Schwartzländer is an expert on the statistics of HIV/AIDS. He talks about the HIV prevalence globally and the importance of early diagnosis and ARV treatment.

XVIII International AIDS Conference in Vienna. Interview with Richard Marlink, Professor at Harvard School of Public Health. He talks about a symposium on the history of HIV/AIDS and future strategies for ending AIDS, that was planned in Boston in 2011.

4th South African AIDS Conference in Durban in 2009. Panel session on data collection and analysis in epidemiological studies on HIV and AIDS., held by Per Strand from the Swedish organization AIDS Accountability International.

XVII International AIDS Conference in Mexico City. Jeffrey Sturchio, Vice President of Merck & Co, talks about the development of protease inhibitors in 1996 and the relationship between the activists and the drug industry.

XVII International AIDS Conference in Mexico City. Michelle Adato and Stuart Gillespie from the International Food Policy Research Institute (IFPRI) talk about how food security work can help decreasing poverty, prevent HIV and maintain the effect of ARV treatment.

XVII International AIDS Conference in Mexico City. Jeffrey Sturchio, Vice President of Merck & Co, talks about the development of protease inhibitors in 1996 and the relationship between the activists and the drug industry.

XVII International AIDS Conference in Mexico City. Ending of a panel session on the vaccine trials of the International AIDS Vaccine Initiative (IAVI). Seth Berkley, Alan Bernstein and Omu Anzala respond to questions from the audience.

Daria Hazuda from MSD explains the virology of HIV and talks about the past clinical studies on ARV, in particular integrase inhibitors, which she has been involved in. She also reflects on HIV as an exceptional virus and how to influence a new generation of HIV researchers.

In the last part of the interview with Dr Anthony Fauci he reflects on the global HIV/AIDS situation and response. He also compares AIDS to other diseases such as the Bird Flu, and discusses the specific social and socioeconomic factors of HIV/AIDS.